Publikationen2011 -2014
Publications 2011 - 2014
2014
200. Giusca S, Kelle S, Nagel E, Buss SJ, Puntmann V, Wellnhofer E, Fleck E, Katus HA, Korosoglou G. Ischemic burden and clinical outcome: is one 'culprit' ischemic segment by dobutamine stress magnetic resonance predictive? PLoS One. 2014 Dec 17;9(12):e115182
199. Doltra A, Messroghli D, Stawowy P, Hassel JH, Gebker R, Leppänen O, Gräfe M, Schneeweis C, Schnackenburg B, Fleck E, Kelle S. Potential reduction of interstitial myocardial fibrosis with renal denervation. J Am Heart Assoc. 2014 Dec;3(6):e001353
198. Hamdan A, Doltra A, Huppertz A, Wellnhofer E, Fleck E, Kelle S. Comparison of coronary magnetic resonance and computed tomography angiography for prediction of cardiovascular events. JACC Cardiovasc Imaging. 2014 Oct;7(10):1063-5
197. Schneeweis C, Qiu J, Schnackenburg B, Berger A, Kelle S, Fleck E, Gebker R.Value of additional strain analysis with feature tracking in dobutamine stress cardiovascular magnetic resonance for detecting coronary artery disease. J Cardiovasc Magn Reson. 2014 Oct 1;16:72
196. Schubert S, Dreysse S, Fleck E, Kelle S. Optical coherence tomography (OCT) to reveal vascular lesions after renal nerve ablation using a novel water-cooled, open-irrigated helical catheter approach. Int J Cardiol. 2014 Aug 23.
195. Nedios S, Romero I, Gerds-Li JH, Fleck E, Kriatselis C. Precordial electrode placement for optimal ECG monitoring: Implications for ambulatory monitor devices and event recorders. J Electrocardiol. 2014 Sep-Oct;47(5):669-76.
194. Mahfoud F, Urban D, Teller D, Linz D, Stawowy P, Hassel JH, Fries P, Dreysse S, Wellnhofer E, Schneider G, Buecker A, Schneeweis C, Doltra A, Schlaich MP, Esler MD, Fleck E, Böhm M, Kelle S. Effect of renal denervation on left ventricular mass and function in patients with resistant hypertension: data from a multi-centre cardiovascular magnetic resonance imaging trial. Eur Heart J. 2014 Sep 1;35(33):2224-31.
193. Doltra A, Skorin A, Hamdan A, Schnackenburg B, Gebker R, Klein C, Nagel E, Fleck E, Kelle S. Comparison of acquisition time and dose for late gadolinium enhancement imaging at 3.0 T in patients with chronic myocardial infarction using Gd-BOPTA. Eur Radiol. 2014 Sep;24(9):2192-200.
192. Jahnke C, Manka R, Kozerke S, Schnackenburg B, Gebker R, Marx N, Paetsch I. Cardiovascular magnetic resonance profiling of coronary atherosclerosis: vessel wall remodelling and related myocardial blood flow alterations. Eur Heart J Cardiovasc Imaging. 2014 Aug
191. Doltra A, Schneeweis C, Fleck E, Kelle S. Cardiac magnetic resonance for prognostic assessment: present applications and future directions. Expert Rev Cardiovasc Ther. 2014 Jun;12(6):771-82.
190. Kriatselis C, Kaufmann J, Nedios S, Tang M, Gerds-Li JH, Fleck E. Prolonged ablation on critical segments of pulmonary vein ostia in paroxysmal atrial fibrillation: a prospective randomized controlled study. Pacing Clin Electrophysiol. 2014 May;37
189. Gebker R, Schneeweis C. Stress testing in the obese: are we finally getting the bigger picture? JACC Cardiovasc Imaging. 2014 May;7(5):473-5.
188. Mirelis JG, Paetsch I, Jahnke C, Ibañez B, Fleck E, Alonso-Pulpon LA, Fuster V, Gebker R. Impact of diastolic wall stress on the diagnostic value of visually interpreted dobutamine stress MR imaging. Int J Cardiol. 2014 Mar 1;172(1):e39-42.
187. Al-Wakeel N, Kelle S, Yigitbasi M, Berger F, Kuehne T. 4D-flow MRI of double aortic arch in a 14-year-old patient. Cardiovasc Diagn Ther. 2014 Feb;4(1):44-6.
186. Kuo YS, Kelle S, Lee C, Hinojar R, Nagel E, Botnar R, Puntmann VO. Contrast-enhanced cardiovascular magnetic resonance imaging of coronary vessel wall: state of art. Expert Rev Cardiovasc Ther. 2014 Feb;12(2):255-63.
185. Schneeweis C, Berger A, Kelle S, Fleck E, Gebker R. Endomyocardial fibrosis in patients with confirmed Churg-Strauss syndrome. Rheumatology (Oxford). 2014 Jan
2013
184. Manka R, Jahnke C, Hucko T, Dietrich T, Gebker R, Schnackenburg B, Graf K, Paetsch I. Reproducibility of small animal cine and scar cardiac magnetic resonance imaging using a clinical 3.0 tesla system. BMC Med Imaging. 2013 Dec 17
183. Kübler D, Gräfe M, Schnackenburg B, Knosalla C, Wassilew K, Hassel JH, Ivanitzkaja E, Messroghli D, Fleck E, Kelle S. T1 and T2 mapping for tissue characterization of cardiac myxoma. Int J Cardiol. 2013 Oct 25;169(1)
182. Doltra A, Stawowy P, Dietrich T, Schneeweis C, Fleck E, Kelle S. Magnetic resonance imaging of cardiovascular fibrosis and inflammation: from clinical practice to animal studies and back. Biomed Res Int. 2013;2013:676489. doi: 10.1155/2013/676489. Epub 2013 Aug 22.
181. Kelle S, Teller DC, Fleck E, Stawowy P. Renal denervation in fibromuscular dysplasia. BMJ Case Rep. 2013 Aug 19;2013.
180. Stawowy P, Kelle S, Fleck E. [PCSK9 as new target in hyperlipidemia treatment.] Herz. 2013 Aug 8. [Epub ahead of print] German.
179. Doltra A, Amundsen BH, Gebker R, Fleck E, Kelle S. Emerging concepts for myocardial late gadolinium enhancement MRI. Curr Cardiol Rev. 2013 Aug;9(3):185-90.
178. Kelle S, Nagel E, Voss A, Hofmann N, Gitsioudis G, Buss SJ, Chiribiri A, Wellnhofer E, Klein C, Schneeweis C, Egnell C, Vierecke J, Berger A, Giannitsis E, Fleck E, Katus HA, Korosoglou G. A bi-center cardiovascular magnetic resonance prognosis study focusing on dobutamine wall motion and late gadolinium enhancement in 3,138 consecutive patients J Am Coll Cardiol. 2013 Jun 4
2012
177. Schneeweis C, Schnackenburg B, Stuber M, Berger A, Schneider U, Yu J, Gebker R, Weiss RG, Fleck E, Kelle S. Delayed contrast-enhanced MRI of the coronary artery wall in takayasu arteritis. PLoS One. 2012
176. Schneeweis C, Fleck E, Gebker R. Myocardial infarction after scuba diving. Eur Heart J. 2012 Sep;33(17):2224
175. Puntmann VO, Nagel E, Hughes AD, Gebker R, Gaddum N, Chowienczyk P, Jahnke C, Mirelis J, Schnackenburg B, Paetsch I, Fleck E. Gender-specific differences in myocardial deformation and aortic stiffness at rest and dobutamine stress. Hypertension. 2012 Mar
174. Puntmann VO, Gebker R, Duckett S, Mirelis J, Schnackenburg B, Graefe M, Razavi R, Fleck E, Nagel E. Left ventricular chamber dimensions and wall thickness by cardiovascular magnetic resonance: comparison with transthoracic echocardiography. Eur Heart J Cardiovasc Imaging. 2013 Mar
173. von Bary C, Dornia C, Eissnert C, Nedios S, Roser M, Hamer OW, Gerds-Li JH, Paetsch I, Jahnke C, Gebker R, Weber S, Fleck E, Kriatselis C Predictive value of left atrial volume measured by non-invasive cardiac imaging in the treatment of paroxysmal atrial fibrillation. . J Interv Card Electrophysiol. 2012 Aug
177. Schneeweis C, Schnackenburg B, Stuber M, Berger A, Schneider U, Yu J, Gebker R, Weiss RG, Fleck E, Kelle S. Delayed contrast-enhanced MRI of the coronary artery wall in takayasu arteritis. PLoS One. 2012
176. Schneeweis C, Fleck E, Gebker R. Myocardial infarction after scuba diving. Eur Heart J. 2012 Sep;33(17):2224
175. Puntmann VO, Nagel E, Hughes AD, Gebker R, Gaddum N, Chowienczyk P, Jahnke C, Mirelis J, Schnackenburg B, Paetsch I, Fleck E. Gender-specific differences in myocardial deformation and aortic stiffness at rest and dobutamine stress. Hypertension. 2012 Mar
174. Puntmann VO, Gebker R, Duckett S, Mirelis J, Schnackenburg B, Graefe M, Razavi R, Fleck E, Nagel E. Left ventricular chamber dimensions and wall thickness by cardiovascular magnetic resonance: comparison with transthoracic echocardiography. Eur Heart J Cardiovasc Imaging. 2013 Mar
173. von Bary C, Dornia C, Eissnert C, Nedios S, Roser M, Hamer OW, Gerds-Li JH, Paetsch I, Jahnke C, Gebker R, Weber S, Fleck E, Kriatselis C Predictive value of left atrial volume measured by non-invasive cardiac imaging in the treatment of paroxysmal atrial fibrillation. . J Interv Card Electrophysiol. 2012 Aug
172. Puntmann VO, Nagel E, Hughes AD, Gebker R, Gaddum N, Chowienczyk P, Jahnke C, Mirelis J, Schnackenburg B, Paetsch I, Fleck E. Gender-Specific Differences in Myocardial Deformation and Aortic Stiffness at Rest and Dobutamine Stress. Hypertension. 2012 Feb 6.
171. Bary C, Dornia C, Eissnert C, Nedios S, Roser M, Hamer OW, Gerds-Li JH, Paetsch I, Jahnke C, Gebker R, Weber S, Fleck E, Kriatselis C.Predictive value of left atrial volume measured by non-invasive cardiac imaging in the treatment of paroxysmal atrial fibrillation. J Interv Card Electrophysiol. 2012 Jan 8.
170. Dietrich T, Hucko T, Schneemann C, Neumann M, Menrad A, Willuda J, Atrott K, Stibenz D, Fleck E, Graf K, Menssen HD.Local delivery of IL-2 reduces atherosclerosis via expansion of regulatory T cells. Atherosclerosis. 2012 Feb;220(2):329-36.
169. Gebker R, Frick M, Jahnke C, Berger A, Schneeweis C, Manka R, Kelle S, Klein C, Schnackenburg B, Fleck E, Paetsch I. Value of additional myocardial perfusion imaging during dobutamine stress magnetic resonance for the assessment of intermediate coronary artery disease. Int J Cardiovasc Imaging. 2012 Jan;28(1):89-97.
2011
168. Manka R, Jahnke C, Gebker R, Schnackenburg B, Paetsch I.Head-to-head comparison of first-pass MR perfusion imaging during adenosine and high-dose dobutamine/atropine stress. Int J Cardiovasc Imaging. 2011 Oct;27(7):995-1002
167. Jahnke C, Fischer J, Gerds-Li JH, Gebker R, Manka R, Fleck E, Paetsch I, Kriatselis C.Serial monitoring of reverse left-atrial remodeling after pulmonary vein isolation in patients with atrial fibrillation: a magnetic resonance imaging study. Int J Cardiol. 2011 Nov 17;153(1):42-6.
166. Gebker R, Jahnke C, Manka R, Hucko T, Schnackenburg B, Kelle S, Klein C, Fleck E, Paetsch I.The role of dobutamine stress cardiovascular magnetic resonance in the clinical management of patients with suspected and known coronary artery disease. J Cardiovasc Magn Reson. 2011 Sep 12;13:46.
165. Yu J, Paetsch I, Schnackenburg B, Fleck E, Weiss RG, Stuber M, Jahnke C.Use of 2D sensitivity encoding for slow-infusion contrast-enhanced isotropic 3-T whole-heart coronary MR angiography. AJR Am J Roentgenol. 2011 Aug;197(2):374-82.
164. Frick M, Paetsch I, den Harder C, Kouwenhoven M, Heese H, Dries S, Schnackenburg B, de Kok W, Gebker R, Fleck E, Manka R, Jahnke C. Fully automatic geometry planning for cardiac MR imaging and reproducibility of functional cardiac parameters. J Magn Reson Imaging. 2011 Aug;34
163. Jahnke C, Furundzija V, Gebker R, Manka R, Frick M, Schnackenburg B, Marx N, Paetsch I. Gender-based prognostic value of pharmacological cardiac magnetic resonance stress testing: head-to-head comparison of adenosine perfusion and dobutamine wall motion imaging. Int J Cardiovasc Imaging. 2011 Jul 6
162. Gebker R, Jahnke C, Manka R, Frick M, Hucko T, Kozerke S, Schnackenburg B, Fleck E, Paetsch I. High spatial resolution myocardial perfusion imaging during high dose dobutamine/atropine stress magnetic resonance using k-t SENSE. Int J Cardiol. 2011 Feb 22.
161. Kelle S, Chiribiri A, Vierecke J, Egnell C, Hamdan A, Jahnke C, Paetsch I, Wellnhofer E, Fleck E, Klein C, Gebker R. Long-term prognostic value of dobutamine stress CMR. JACC Cardiovasc Imaging. 2011 Feb;4(2):161-72.
160. Jahnke C, Fischer J, Mirelis JG, Kriatselis C, Gerds-Li JH, Gebker R, Manka R, Schnackenburg B, Fleck E, Paetsch I. Cardiovascular magnetic resonance imaging for accurate sizing of the left atrium: predictability of pulmonary vein isolation success in patients with atrial fibrillation. J Magn Reson Imaging. 2011 Feb;33(2):455-63.
159. Koch H, Bousseljot RD, Kosch O, Jahnke C, Paetsch I, Fleck E, Schnackenburg B. A reference dataset for verifying numerical electrophysiological heart models. Biomed Eng Online. 2011 Jan 27
158. Manka R, Jahnke C, Kozerke S, Vitanis V, Crelier G, Gebker R, Schnackenburg B, Boesiger P, Fleck E, Paetsch I. Dynamic 3-dimensional stress cardiac magnetic resonance perfusion imaging: detection of coronary artery disease and volumetry of myocardial hypoenhancement before and after coronary stenting. J Am Coll Cardiol. 2011 Jan 25;57(4):437-44.
157. Hamdan A, Asbach P, Wellnhofer E, Klein C, Gebker R, Kelle S, Kilian H, Huppertz A, Fleck E. A prospective study for comparison of MR and CT imaging for detection of coronary artery stenosis. JACC Cardiovasc Imaging. 2011 Jan;4(1):50-61.
200. Giusca S, Kelle S, Nagel E, Buss SJ, Puntmann V, Wellnhofer E, Fleck E, Katus HA, Korosoglou G. Ischemic burden and clinical outcome: is one 'culprit' ischemic segment by dobutamine stress magnetic resonance predictive? PLoS One. 2014 Dec 17;9(12):e115182
199. Doltra A, Messroghli D, Stawowy P, Hassel JH, Gebker R, Leppänen O, Gräfe M, Schneeweis C, Schnackenburg B, Fleck E, Kelle S. Potential reduction of interstitial myocardial fibrosis with renal denervation. J Am Heart Assoc. 2014 Dec;3(6):e001353
198. Hamdan A, Doltra A, Huppertz A, Wellnhofer E, Fleck E, Kelle S. Comparison of coronary magnetic resonance and computed tomography angiography for prediction of cardiovascular events. JACC Cardiovasc Imaging. 2014 Oct;7(10):1063-5
197. Schneeweis C, Qiu J, Schnackenburg B, Berger A, Kelle S, Fleck E, Gebker R.Value of additional strain analysis with feature tracking in dobutamine stress cardiovascular magnetic resonance for detecting coronary artery disease. J Cardiovasc Magn Reson. 2014 Oct 1;16:72
196. Schubert S, Dreysse S, Fleck E, Kelle S. Optical coherence tomography (OCT) to reveal vascular lesions after renal nerve ablation using a novel water-cooled, open-irrigated helical catheter approach. Int J Cardiol. 2014 Aug 23.
195. Nedios S, Romero I, Gerds-Li JH, Fleck E, Kriatselis C. Precordial electrode placement for optimal ECG monitoring: Implications for ambulatory monitor devices and event recorders. J Electrocardiol. 2014 Sep-Oct;47(5):669-76.
194. Mahfoud F, Urban D, Teller D, Linz D, Stawowy P, Hassel JH, Fries P, Dreysse S, Wellnhofer E, Schneider G, Buecker A, Schneeweis C, Doltra A, Schlaich MP, Esler MD, Fleck E, Böhm M, Kelle S. Effect of renal denervation on left ventricular mass and function in patients with resistant hypertension: data from a multi-centre cardiovascular magnetic resonance imaging trial. Eur Heart J. 2014 Sep 1;35(33):2224-31.
193. Doltra A, Skorin A, Hamdan A, Schnackenburg B, Gebker R, Klein C, Nagel E, Fleck E, Kelle S. Comparison of acquisition time and dose for late gadolinium enhancement imaging at 3.0 T in patients with chronic myocardial infarction using Gd-BOPTA. Eur Radiol. 2014 Sep;24(9):2192-200.
192. Jahnke C, Manka R, Kozerke S, Schnackenburg B, Gebker R, Marx N, Paetsch I. Cardiovascular magnetic resonance profiling of coronary atherosclerosis: vessel wall remodelling and related myocardial blood flow alterations. Eur Heart J Cardiovasc Imaging. 2014 Aug
191. Doltra A, Schneeweis C, Fleck E, Kelle S. Cardiac magnetic resonance for prognostic assessment: present applications and future directions. Expert Rev Cardiovasc Ther. 2014 Jun;12(6):771-82.
190. Kriatselis C, Kaufmann J, Nedios S, Tang M, Gerds-Li JH, Fleck E. Prolonged ablation on critical segments of pulmonary vein ostia in paroxysmal atrial fibrillation: a prospective randomized controlled study. Pacing Clin Electrophysiol. 2014 May;37
189. Gebker R, Schneeweis C. Stress testing in the obese: are we finally getting the bigger picture? JACC Cardiovasc Imaging. 2014 May;7(5):473-5.
188. Mirelis JG, Paetsch I, Jahnke C, Ibañez B, Fleck E, Alonso-Pulpon LA, Fuster V, Gebker R. Impact of diastolic wall stress on the diagnostic value of visually interpreted dobutamine stress MR imaging. Int J Cardiol. 2014 Mar 1;172(1):e39-42.
187. Al-Wakeel N, Kelle S, Yigitbasi M, Berger F, Kuehne T. 4D-flow MRI of double aortic arch in a 14-year-old patient. Cardiovasc Diagn Ther. 2014 Feb;4(1):44-6.
186. Kuo YS, Kelle S, Lee C, Hinojar R, Nagel E, Botnar R, Puntmann VO. Contrast-enhanced cardiovascular magnetic resonance imaging of coronary vessel wall: state of art. Expert Rev Cardiovasc Ther. 2014 Feb;12(2):255-63.
185. Schneeweis C, Berger A, Kelle S, Fleck E, Gebker R. Endomyocardial fibrosis in patients with confirmed Churg-Strauss syndrome. Rheumatology (Oxford). 2014 Jan
2013
184. Manka R, Jahnke C, Hucko T, Dietrich T, Gebker R, Schnackenburg B, Graf K, Paetsch I. Reproducibility of small animal cine and scar cardiac magnetic resonance imaging using a clinical 3.0 tesla system. BMC Med Imaging. 2013 Dec 17
183. Kübler D, Gräfe M, Schnackenburg B, Knosalla C, Wassilew K, Hassel JH, Ivanitzkaja E, Messroghli D, Fleck E, Kelle S. T1 and T2 mapping for tissue characterization of cardiac myxoma. Int J Cardiol. 2013 Oct 25;169(1)
182. Doltra A, Stawowy P, Dietrich T, Schneeweis C, Fleck E, Kelle S. Magnetic resonance imaging of cardiovascular fibrosis and inflammation: from clinical practice to animal studies and back. Biomed Res Int. 2013;2013:676489. doi: 10.1155/2013/676489. Epub 2013 Aug 22.
181. Kelle S, Teller DC, Fleck E, Stawowy P. Renal denervation in fibromuscular dysplasia. BMJ Case Rep. 2013 Aug 19;2013.
180. Stawowy P, Kelle S, Fleck E. [PCSK9 as new target in hyperlipidemia treatment.] Herz. 2013 Aug 8. [Epub ahead of print] German.
179. Doltra A, Amundsen BH, Gebker R, Fleck E, Kelle S. Emerging concepts for myocardial late gadolinium enhancement MRI. Curr Cardiol Rev. 2013 Aug;9(3):185-90.
178. Kelle S, Nagel E, Voss A, Hofmann N, Gitsioudis G, Buss SJ, Chiribiri A, Wellnhofer E, Klein C, Schneeweis C, Egnell C, Vierecke J, Berger A, Giannitsis E, Fleck E, Katus HA, Korosoglou G. A bi-center cardiovascular magnetic resonance prognosis study focusing on dobutamine wall motion and late gadolinium enhancement in 3,138 consecutive patients J Am Coll Cardiol. 2013 Jun 4
2012
177. Schneeweis C, Schnackenburg B, Stuber M, Berger A, Schneider U, Yu J, Gebker R, Weiss RG, Fleck E, Kelle S. Delayed contrast-enhanced MRI of the coronary artery wall in takayasu arteritis. PLoS One. 2012
176. Schneeweis C, Fleck E, Gebker R. Myocardial infarction after scuba diving. Eur Heart J. 2012 Sep;33(17):2224
175. Puntmann VO, Nagel E, Hughes AD, Gebker R, Gaddum N, Chowienczyk P, Jahnke C, Mirelis J, Schnackenburg B, Paetsch I, Fleck E. Gender-specific differences in myocardial deformation and aortic stiffness at rest and dobutamine stress. Hypertension. 2012 Mar
174. Puntmann VO, Gebker R, Duckett S, Mirelis J, Schnackenburg B, Graefe M, Razavi R, Fleck E, Nagel E. Left ventricular chamber dimensions and wall thickness by cardiovascular magnetic resonance: comparison with transthoracic echocardiography. Eur Heart J Cardiovasc Imaging. 2013 Mar
173. von Bary C, Dornia C, Eissnert C, Nedios S, Roser M, Hamer OW, Gerds-Li JH, Paetsch I, Jahnke C, Gebker R, Weber S, Fleck E, Kriatselis C Predictive value of left atrial volume measured by non-invasive cardiac imaging in the treatment of paroxysmal atrial fibrillation. . J Interv Card Electrophysiol. 2012 Aug
177. Schneeweis C, Schnackenburg B, Stuber M, Berger A, Schneider U, Yu J, Gebker R, Weiss RG, Fleck E, Kelle S. Delayed contrast-enhanced MRI of the coronary artery wall in takayasu arteritis. PLoS One. 2012
176. Schneeweis C, Fleck E, Gebker R. Myocardial infarction after scuba diving. Eur Heart J. 2012 Sep;33(17):2224
175. Puntmann VO, Nagel E, Hughes AD, Gebker R, Gaddum N, Chowienczyk P, Jahnke C, Mirelis J, Schnackenburg B, Paetsch I, Fleck E. Gender-specific differences in myocardial deformation and aortic stiffness at rest and dobutamine stress. Hypertension. 2012 Mar
174. Puntmann VO, Gebker R, Duckett S, Mirelis J, Schnackenburg B, Graefe M, Razavi R, Fleck E, Nagel E. Left ventricular chamber dimensions and wall thickness by cardiovascular magnetic resonance: comparison with transthoracic echocardiography. Eur Heart J Cardiovasc Imaging. 2013 Mar
173. von Bary C, Dornia C, Eissnert C, Nedios S, Roser M, Hamer OW, Gerds-Li JH, Paetsch I, Jahnke C, Gebker R, Weber S, Fleck E, Kriatselis C Predictive value of left atrial volume measured by non-invasive cardiac imaging in the treatment of paroxysmal atrial fibrillation. . J Interv Card Electrophysiol. 2012 Aug
172. Puntmann VO, Nagel E, Hughes AD, Gebker R, Gaddum N, Chowienczyk P, Jahnke C, Mirelis J, Schnackenburg B, Paetsch I, Fleck E. Gender-Specific Differences in Myocardial Deformation and Aortic Stiffness at Rest and Dobutamine Stress. Hypertension. 2012 Feb 6.
171. Bary C, Dornia C, Eissnert C, Nedios S, Roser M, Hamer OW, Gerds-Li JH, Paetsch I, Jahnke C, Gebker R, Weber S, Fleck E, Kriatselis C.Predictive value of left atrial volume measured by non-invasive cardiac imaging in the treatment of paroxysmal atrial fibrillation. J Interv Card Electrophysiol. 2012 Jan 8.
170. Dietrich T, Hucko T, Schneemann C, Neumann M, Menrad A, Willuda J, Atrott K, Stibenz D, Fleck E, Graf K, Menssen HD.Local delivery of IL-2 reduces atherosclerosis via expansion of regulatory T cells. Atherosclerosis. 2012 Feb;220(2):329-36.
169. Gebker R, Frick M, Jahnke C, Berger A, Schneeweis C, Manka R, Kelle S, Klein C, Schnackenburg B, Fleck E, Paetsch I. Value of additional myocardial perfusion imaging during dobutamine stress magnetic resonance for the assessment of intermediate coronary artery disease. Int J Cardiovasc Imaging. 2012 Jan;28(1):89-97.
2011
168. Manka R, Jahnke C, Gebker R, Schnackenburg B, Paetsch I.Head-to-head comparison of first-pass MR perfusion imaging during adenosine and high-dose dobutamine/atropine stress. Int J Cardiovasc Imaging. 2011 Oct;27(7):995-1002
167. Jahnke C, Fischer J, Gerds-Li JH, Gebker R, Manka R, Fleck E, Paetsch I, Kriatselis C.Serial monitoring of reverse left-atrial remodeling after pulmonary vein isolation in patients with atrial fibrillation: a magnetic resonance imaging study. Int J Cardiol. 2011 Nov 17;153(1):42-6.
166. Gebker R, Jahnke C, Manka R, Hucko T, Schnackenburg B, Kelle S, Klein C, Fleck E, Paetsch I.The role of dobutamine stress cardiovascular magnetic resonance in the clinical management of patients with suspected and known coronary artery disease. J Cardiovasc Magn Reson. 2011 Sep 12;13:46.
165. Yu J, Paetsch I, Schnackenburg B, Fleck E, Weiss RG, Stuber M, Jahnke C.Use of 2D sensitivity encoding for slow-infusion contrast-enhanced isotropic 3-T whole-heart coronary MR angiography. AJR Am J Roentgenol. 2011 Aug;197(2):374-82.
164. Frick M, Paetsch I, den Harder C, Kouwenhoven M, Heese H, Dries S, Schnackenburg B, de Kok W, Gebker R, Fleck E, Manka R, Jahnke C. Fully automatic geometry planning for cardiac MR imaging and reproducibility of functional cardiac parameters. J Magn Reson Imaging. 2011 Aug;34
163. Jahnke C, Furundzija V, Gebker R, Manka R, Frick M, Schnackenburg B, Marx N, Paetsch I. Gender-based prognostic value of pharmacological cardiac magnetic resonance stress testing: head-to-head comparison of adenosine perfusion and dobutamine wall motion imaging. Int J Cardiovasc Imaging. 2011 Jul 6
162. Gebker R, Jahnke C, Manka R, Frick M, Hucko T, Kozerke S, Schnackenburg B, Fleck E, Paetsch I. High spatial resolution myocardial perfusion imaging during high dose dobutamine/atropine stress magnetic resonance using k-t SENSE. Int J Cardiol. 2011 Feb 22.
161. Kelle S, Chiribiri A, Vierecke J, Egnell C, Hamdan A, Jahnke C, Paetsch I, Wellnhofer E, Fleck E, Klein C, Gebker R. Long-term prognostic value of dobutamine stress CMR. JACC Cardiovasc Imaging. 2011 Feb;4(2):161-72.
160. Jahnke C, Fischer J, Mirelis JG, Kriatselis C, Gerds-Li JH, Gebker R, Manka R, Schnackenburg B, Fleck E, Paetsch I. Cardiovascular magnetic resonance imaging for accurate sizing of the left atrium: predictability of pulmonary vein isolation success in patients with atrial fibrillation. J Magn Reson Imaging. 2011 Feb;33(2):455-63.
159. Koch H, Bousseljot RD, Kosch O, Jahnke C, Paetsch I, Fleck E, Schnackenburg B. A reference dataset for verifying numerical electrophysiological heart models. Biomed Eng Online. 2011 Jan 27
158. Manka R, Jahnke C, Kozerke S, Vitanis V, Crelier G, Gebker R, Schnackenburg B, Boesiger P, Fleck E, Paetsch I. Dynamic 3-dimensional stress cardiac magnetic resonance perfusion imaging: detection of coronary artery disease and volumetry of myocardial hypoenhancement before and after coronary stenting. J Am Coll Cardiol. 2011 Jan 25;57(4):437-44.
157. Hamdan A, Asbach P, Wellnhofer E, Klein C, Gebker R, Kelle S, Kilian H, Huppertz A, Fleck E. A prospective study for comparison of MR and CT imaging for detection of coronary artery stenosis. JACC Cardiovasc Imaging. 2011 Jan;4(1):50-61.
value
Contact us
At the social networks you will regularly find out more about our corporation.
Co- Partner
